Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study

Langenbecks Arch Surg. 2019 Aug;404(5):581-588. doi: 10.1007/s00423-019-01807-9. Epub 2019 Aug 14.

Abstract

Background: Although the current nodal staging system for gallbladder cancer (GBC) was changed based on the number of positive lymph nodes (PLN), it needs to be evaluated in various situations.

Methods: We reviewed the clinical data for 398 patients with resected GBC and compared nodal staging systems based on the number of PLNs, the positive/retrieved LN ratio (LNR), and the log odds of positive LN (LODDS). Prognostic performance was evaluated using the C-index.

Results: Subgroups were formed on the basis of an restricted cubic spline plot as follows: PLN 3 (PLN = 0, 1-2, ≥ 3); PLN 4 (PLN = 0, 1-3, ≥ 4); LNR (LNR = 0, 0-0.269, ≥ 0.27); and LODDS (LODDS < - 0.8, - 0.8-0, ≥ 0). The oncological outcome differed significantly between subgroups in each system. In all patients with GBC, PLN 4 (C-index 0.730) and PLN 3 (C-index 0.734) were the best prognostic discriminators of survival and recurrence, respectively. However, for retrieved LN (RLN) ≥ 6, LODDS was the best discriminator for survival (C-index 0.852).

Conclusion: The nodal staging system based on PLN was the optimal prognostic discriminator in patients with RLN < 6, whereas the LODDS system is adequate for RLN ≥ 6. The following nodal staging system considers applying different systems according to the RLN.

Keywords: Gallbladder cancer; Prognostic performance; Restricted cubic spline model; Staging system.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Cholecystectomy
  • Disease-Free Survival
  • Female
  • Gallbladder Neoplasms / mortality*
  • Gallbladder Neoplasms / pathology*
  • Gallbladder Neoplasms / therapy
  • Humans
  • Lymph Node Excision
  • Lymph Nodes / pathology*
  • Male
  • Middle Aged
  • Neoplasm Staging*
  • Predictive Value of Tests
  • Prognosis
  • Proportional Hazards Models
  • Reproducibility of Results
  • Retrospective Studies
  • Survival Rate